Literature DB >> 26066553

Intracellular survival of Candida glabrata in macrophages: immune evasion and persistence.

Lydia Kasper1, Katja Seider2, Bernhard Hube3.   

Abstract

Candida glabrata is a successful human opportunistic pathogen which causes superficial but also life-threatening systemic infections. During infection, C. glabrata has to cope with cells of the innate immune system such as macrophages, which belong to the first line of defense against invading pathogens. Candida glabrata is able to survive and even replicate inside macrophages while causing surprisingly low damage and cytokine release. Here, we present an overview of recent studies dealing with the interaction of C. glabrata with macrophages, from phagocytosis to intracellular growth and escape. We review the strategies of C. glabrata that permit intracellular survival and replication, including poor host cell activation, modification of phagosome maturation and phagosome pH, adaptation to antimicrobial activities, and mechanisms to overcome the nutrient limitations within the phagosome. In summary, these studies suggest that survival within macrophages may be an immune evasion and persistence strategy of C. glabrata during infection. © FEMS 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Candida glabrata; immune evasion; macrophage; persistence; replication; survival

Mesh:

Year:  2015        PMID: 26066553     DOI: 10.1093/femsyr/fov042

Source DB:  PubMed          Journal:  FEMS Yeast Res        ISSN: 1567-1356            Impact factor:   2.796


  30 in total

1.  Antifungal Properties of Cationic Phenylene Ethynylenes and Their Impact on β-Glucan Exposure.

Authors:  Harry C Pappas; Rina Sylejmani; Matthew S Graus; Patrick L Donabedian; David G Whitten; Aaron K Neumann
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

2.  Mannan Molecular Substructures Control Nanoscale Glucan Exposure in Candida.

Authors:  Matthew S Graus; Michael J Wester; Douglas W Lowman; David L Williams; Michael D Kruppa; Carmen M Martinez; Jesse M Young; Harry C Pappas; Keith A Lidke; Aaron K Neumann
Journal:  Cell Rep       Date:  2018-08-28       Impact factor: 9.423

3.  Copper Acts Synergistically With Fluconazole in Candida glabrata by Compromising Drug Efflux, Sterol Metabolism, and Zinc Homeostasis.

Authors:  Ana Gaspar-Cordeiro; Catarina Amaral; Vânia Pobre; Wilson Antunes; Ana Petronilho; Paulo Paixão; António P Matos; Catarina Pimentel
Journal:  Front Microbiol       Date:  2022-06-14       Impact factor: 6.064

Review 4.  The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives.

Authors:  Christophe d'Enfert; Ann-Kristin Kaune; Leovigildo-Rey Alaban; Sayoni Chakraborty; Nathaniel Cole; Margot Delavy; Daria Kosmala; Benoît Marsaux; Ricardo Fróis-Martins; Moran Morelli; Diletta Rosati; Marisa Valentine; Zixuan Xie; Yoan Emritloll; Peter A Warn; Frédéric Bequet; Marie-Elisabeth Bougnoux; Stephanie Bornes; Mark S Gresnigt; Bernhard Hube; Ilse D Jacobsen; Mélanie Legrand; Salomé Leibundgut-Landmann; Chaysavanh Manichanh; Carol A Munro; Mihai G Netea; Karla Queiroz; Karine Roget; Vincent Thomas; Claudia Thoral; Pieter Van den Abbeele; Alan W Walker; Alistair J P Brown
Journal:  FEMS Microbiol Rev       Date:  2021-05-05       Impact factor: 16.408

5.  A homologous overexpression system to study roles of drug transporters in Candida glabrata.

Authors:  Sonam Kumari; Mohit Kumar; Nitesh Kumar Khandelwal; Ajay Kumar Pandey; Priyanka Bhakt; Rupinder Kaur; Rajendra Prasad; Naseem A Gaur
Journal:  FEMS Yeast Res       Date:  2020-06-01       Impact factor: 2.796

6.  Epitope-Based Peptide Vaccine Design against Fructose Bisphosphate Aldolase of Candida glabrata: An Immunoinformatics Approach.

Authors:  Lina Mohamed Elamin Elhasan; Mohamed B Hassan; Reham M Elhassan; Fatima A Abdelrhman; Essam A Salih; Asma Ibrahim H; Amna A Mohamed; Hozaifa S Osman; Marwa Saad M Khalil; Athar A Alsafi; Abeer Babiker Idris; Mohamed A Hassan
Journal:  J Immunol Res       Date:  2021-05-04       Impact factor: 4.818

7.  Genome engineering in the yeast pathogen Candida glabrata using the CRISPR-Cas9 system.

Authors:  Ludovic Enkler; Delphine Richer; Anthony L Marchand; Dominique Ferrandon; Fabrice Jossinet
Journal:  Sci Rep       Date:  2016-10-21       Impact factor: 4.379

8.  Otopathogenic Pseudomonas aeruginosa Enters and Survives Inside Macrophages.

Authors:  Rahul Mittal; Christopher V Lisi; Hansi Kumari; M'hamed Grati; Patricia Blackwelder; Denise Yan; Chaitanya Jain; Kalai Mathee; Paulo H Weckwerth; Xue Z Liu
Journal:  Front Microbiol       Date:  2016-11-18       Impact factor: 5.640

9.  Relationship between the Antifungal Susceptibility Profile and the Production of Virulence-Related Hydrolytic Enzymes in Brazilian Clinical Strains of Candida glabrata.

Authors:  Maria Helena Galdino Figueiredo-Carvalho; Lívia de Souza Ramos; Leonardo Silva Barbedo; Jean Carlos Almeida de Oliveira; André Luis Souza Dos Santos; Rodrigo Almeida-Paes; Rosely Maria Zancopé-Oliveira
Journal:  Mediators Inflamm       Date:  2017-07-26       Impact factor: 4.711

10.  A Murine Model of Candida glabrata Vaginitis Shows No Evidence of an Inflammatory Immunopathogenic Response.

Authors:  Evelyn E Nash; Brian M Peters; Elizabeth A Lilly; Mairi C Noverr; Paul L Fidel
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.